Public Employees Retirement Association of Colorado Sells 10,052 Shares of Colgate-Palmolive (NYSE:CL)

Public Employees Retirement Association of Colorado decreased its stake in shares of Colgate-Palmolive (NYSE:CL) by 8.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 108,833 shares of the company’s stock after selling 10,052 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Colgate-Palmolive were worth $9,800,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Legacy Trust grew its position in shares of Colgate-Palmolive by 1.7% in the first quarter. Legacy Trust now owns 6,925 shares of the company’s stock valued at $624,000 after purchasing an additional 116 shares during the last quarter. Checchi Capital Advisers LLC grew its holdings in Colgate-Palmolive by 1.5% in the 1st quarter. Checchi Capital Advisers LLC now owns 7,829 shares of the company’s stock valued at $705,000 after buying an additional 118 shares in the last quarter. Regal Investment Advisors LLC increased its position in Colgate-Palmolive by 1.6% during the 4th quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock worth $604,000 after buying an additional 121 shares during the period. M&G Investment Management Ltd. lifted its holdings in shares of Colgate-Palmolive by 0.3% during the fourth quarter. M&G Investment Management Ltd. now owns 49,269 shares of the company’s stock worth $3,942,000 after buying an additional 125 shares in the last quarter. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors boosted its position in shares of Colgate-Palmolive by 3.8% in the first quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 3,374 shares of the company’s stock valued at $304,000 after acquiring an additional 125 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $100.88 on Tuesday. The firm has a 50 day simple moving average of $95.96 and a 200 day simple moving average of $90.34. The company has a market cap of $82.77 billion, a price-to-earnings ratio of 31.92, a PEG ratio of 3.57 and a beta of 0.39. Colgate-Palmolive has a one year low of $67.62 and a one year high of $101.42. The company has a debt-to-equity ratio of 13.21, a current ratio of 0.42 and a quick ratio of 0.28.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The company had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same quarter last year, the business posted $0.77 EPS. Colgate-Palmolive’s revenue for the quarter was up 4.9% on a year-over-year basis. Research analysts predict that Colgate-Palmolive will post 3.55 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.98%. The ex-dividend date is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Analyst Ratings Changes

Several analysts have weighed in on CL shares. Jefferies Financial Group cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. Morgan Stanley increased their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday. Bank of America raised their price objective on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday. Finally, Barclays boosted their price target on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research note on Monday. Six research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $99.42.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider John W. Kooyman sold 3,497 shares of the stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the sale, the insider now owns 3,181 shares of the company’s stock, valued at $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.